{"entity":{"type":"insider","cik":"0001605431","url":"/insider/0001605431","json_url":"/insider/0001605431.json","name":"aeris Capital Equity Investments, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2014-11-24","last":"2015-03-17","span_basis":"filed_date"},"name_variants":[{"name":"aeris Capital Equity Investments, L.P.","source":"filing","n_filings":7,"first_seen":"2014-11-24","last_seen":"2015-03-17"}],"transactions":[{"id":8792848,"accession":"0001209191-15-026796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-026796","line_url":"/filing/0001209191-15-026796#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":6030500.0,"total_display":"6,030,500.00","total_whole":"6,030,500","shares_owned_after":1662128.0,"shares_owned_after_display":"1,662,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-13","filed_date":"2015-03-17","scope":"insider"},{"id":6373697,"accession":"0001181431-14-038038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-038038","line_url":"/filing/0001181431-14-038038#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105225.0,"shares_display":"105,225","price_per_share":14.505,"price_display":"14.50","price_state":"stated","total_value":1526288.625,"total_display":"1,526,288.62","total_whole":"1,526,289","shares_owned_after":2012128.0,"shares_owned_after_display":"2,012,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-04","scope":"insider"},{"id":6373693,"accession":"0001181431-14-038038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-038038","line_url":"/filing/0001181431-14-038038#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6400.0,"shares_display":"6,400","price_per_share":14.514,"price_display":"14.51","price_state":"stated","total_value":92889.6,"total_display":"92,889.60","total_whole":"92,890","shares_owned_after":2117353.0,"shares_owned_after_display":"2,117,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-04","scope":"insider"},{"id":6373629,"accession":"0001181431-14-037661","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-037661","line_url":"/filing/0001181431-14-037661#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12815.0,"shares_display":"12,815","price_per_share":14.514,"price_display":"14.51","price_state":"stated","total_value":185996.91,"total_display":"185,996.91","total_whole":"185,997","shares_owned_after":2123753.0,"shares_owned_after_display":"2,123,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6373625,"accession":"0001181431-14-037661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037661","line_url":"/filing/0001181431-14-037661#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":14.926,"price_display":"14.93","price_state":"stated","total_value":11940.8,"total_display":"11,940.80","total_whole":"11,941","shares_owned_after":2136568.0,"shares_owned_after_display":"2,136,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-12-02","scope":"insider"},{"id":6786804,"accession":"0001181431-14-037463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037463","line_url":"/filing/0001181431-14-037463#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":14.773,"price_display":"14.77","price_state":"stated","total_value":184662.5,"total_display":"184,662.50","total_whole":"184,663","shares_owned_after":2137368.0,"shares_owned_after_display":"2,137,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-11-28","scope":"insider"},{"id":6258009,"accession":"0001181431-14-037413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-037413","line_url":"/filing/0001181431-14-037413#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5600.0,"shares_display":"5,600","price_per_share":14.852,"price_display":"14.85","price_state":"stated","total_value":83171.2,"total_display":"83,171.20","total_whole":"83,171","shares_owned_after":2149868.0,"shares_owned_after_display":"2,149,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-26","scope":"insider"},{"id":6258005,"accession":"0001181431-14-037413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037413","line_url":"/filing/0001181431-14-037413#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":14.857,"price_display":"14.86","price_state":"stated","total_value":65370.8,"total_display":"65,370.80","total_whole":"65,371","shares_owned_after":2155468.0,"shares_owned_after_display":"2,155,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-26","scope":"insider"},{"id":6288416,"accession":"0001181431-14-037335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037335","line_url":"/filing/0001181431-14-037335#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8760.0,"shares_display":"8,760","price_per_share":14.815,"price_display":"14.82","price_state":"stated","total_value":129779.4,"total_display":"129,779.40","total_whole":"129,779","shares_owned_after":2159868.0,"shares_owned_after_display":"2,159,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-25","scope":"insider"},{"id":6463287,"accession":"0001181431-14-037189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037189","line_url":"/filing/0001181431-14-037189#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001605431","owner_name":"aeris Capital Equity Investments, L.P.","owner_display_name":"aeris Capital Equity Investments, L.P.","owner_url":"/insider/0001605431","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":14.6935,"price_display":"14.69","price_state":"stated","total_value":51427.25,"total_display":"51,427.25","total_whole":"51,427","shares_owned_after":2168628.0,"shares_owned_after_display":"2,168,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001328143","name":"Adamas Pharmaceuticals Inc","url":"/issuer/0001328143","role":"Ten percent owner","n_filings":7,"first_seen":"2014-11-24","last_seen":"2015-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001605431","retrieved_at":"2026-08-25T19:13:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}